The Gilead stock price has seen a massive downturn lately.
Since last month, GILD stock has fallen nearly 20% to $82 a share.
By Alex McGuire, Associate Editor, Money Morning • @AlexMcGuire92 - • Print | Email
The Gilead stock price has seen a massive downturn lately.
Since last month, GILD stock has fallen nearly 20% to $82 a share.
But we see shares of the biotech giant heading sharply higher by next year for two big reasons...
By Money Morning Staff Reports, Money Morning - • Print | Email
The best stocks to buy today can come from many different areas, but they all have a few things in common.
We found five stocks to buy now that have these factors – so you can start profiting better than other investors.
Check out our latest list of stocks to buy today...
By Diane Alter, Contributing Writer, Money Morning - • Print | Email
Our Gilead stock price prediction shows gains ahead, even after Gilead Sciences Inc. (Nasdaq: GILD) shares have fallen more than 7% since the beginning of August.
You see, the Gilead stock price recently got caught up in a sell-off of biotech stocks as regulators continue to investigate companies for drug price gouging.
But the stock price's drop has only made GILD stock more attractive